There is no defined precision treatment approach or even clear first-line medication for MD or HNF1B-diabetes, with the evidence for specific treatment in HNF1B-diabetes and MD being of low quality with no trials and very few studies. The gene discussed is HNF1B; the disease is diabetes mellitus.